BibTex RIS Cite

MK-801 Verilen Ratlarm Cerebellumun'da Makromolekiiler Oksidasyon ve Cape'nin Koruyucu Etkisi

Year 2006, Volume: 7 Issue: 3, - , 01.12.2006

Abstract

References

  • Olney JW, Newcomer JW, Farber NB. NMDA
  • receptor hypofunction model of schizophrenia. J
  • Psychiatr Res, 1999; 33:523-33.
  • Javitt DC, Zukin SR. Recent advances in the
  • phencyclidine model of schizophrenia. Am J
  • Psychiatry, 1991; [48:1301-8.
  • Corso TD, Sesma MA, Tenkova TI, Der TC,
  • Wozniak DF, Farber NB, Olney JW. Multifocal brain
  • damage induced by phencyclidine is augmented by
  • pilocarpine. Brain Res, 1997; 75221-14.
  • Haring R, Pellegrini-Giampietro DE, Zukin SR,
  • Zukin RS, Scheideler MA. High efŞciency
  • reconstitution of a phencyclidine/MK-801 receptor
  • binding site solubilized from rat forebrain
  • membranes. Mol Pharmacol. 1991; 402666-73.
  • Ferrer-Montiel AV, Sun W, Montal M. Molecular
  • design of the N—methyl-D-aspartate receptor binding
  • site for phencyclidine and dizolcipine. Proc Natl
  • Acad Sci U S A. 1995; 92:8021-5.
  • Hoffman DC. Typical and atypical neuroleptics
  • antagonize MK-801-induced locomotion and
  • stereotypy in rats. J Neural Transm Gen Sect. 1992;89:1-10.
  • Andine P, Widerrnark N, Axelsson R et al..
  • Characterization of MK-SOl-induced behavior as a
  • putative rat model of pschosis. JPET. 1999;290: 1393-1408.
  • Mastropaolo J, Rosse RB, Deutsch Sl. Anabasine, a
  • selective nicotinic acetylcholine receptor agonist,
  • antagonizes MK-801-elicited mouse popping
  • behavior, an animal model of schizophrenia. Behav
  • Brain Res. 2004. 31; 53z419-22.
  • Deutsch SI, Rosse RB, Billingslea EN, Bellack AS,
  • Mastropaolo J. Modulation of MK-801-elicited
  • mouse popping behavior by galantamine is complex
  • and dose-dependent. Life Sci. 2003. 7318:2355-61. . Rung JP, Carlsson A, Ryden Markinhuhta K,
  • Carlsson ML. (+)-MK—801 induced social withdrawal
  • in rats; a model for negative symptoms of
  • schizophrenia. Prog Neuropsychopharmacol Biol
  • Psychiatry. 2005. 29:827-32. . Nakki R, Sharp F., Sagar SM. FOS expression in the
  • brainstem and cerebellum following phencyclidine
  • and MK801. J Neurosci Res. 1996; 43:203-12.
  • Cortas, N. K., Wakid, N. W.:Determination of
  • inorganic nitrate in serum and urine by a kinetic
  • cadmium-reduction method. Clin Chem
  • ;36:1440-1443. . Esterbauer H, Cheeseman KH. Determination of
  • aldehydic lipid peroxidation products:
  • Malonaldehyde and 4-hydroxynonenal. ln Methods in
  • MK-801 Verilen Rat/arm Cerebellumun 'da Makromolekiiler Oksidasyon ve Cape ’nin Koruyucu Etkisi / 67 The Macromoleculer Oxıdation in Cerebellum of Rat Exposed To NIK-80] and The Protective Effect of Cape
  • EnzymolOgy, V 186, Oxygen radicals in biological
  • systems edited by Packer L, Glazer AN. Academic
  • Press, California, 1990, pp 407—421. . Packer L, Glazer NA. Determination of Carbonyl
  • Content in Oxidatively ModiŞed Proteins, Methods in
  • Enzymology. California. 1990;186:464-479. . Lowry O, Rosenbraugh N, Farr L, Rondall R. Protein
  • measurement with the folin-phenol reagent. J Biol
  • Chem 1951;183:265-275. . Mahadik SP, Evans D, Lal H. Oxidative stress and ro—
  • le of antioxidant and omega-3 essential fatty acid
  • supplementation in schizophrenia. Prog
  • Neuropsychopharmacol Biol Psychiatry. 2001; 25: 463-93. . Mahadik SP, Mukherjee S, Scheffer R, Correnti EE,
  • Mahadik JS. Elevated plasma lipid peroxides at the
  • onset of nonaffective psychosis. Biol Psychiatry.
  • ; 43:674-9. .Mates JM, Perez-Gomez C, De Castro IN.
  • Antioxidant enzymes and human diseases. Clin.
  • Biocehmistry. 1999; 32: 595—603. . Akyol O, Herken H, Uz E, Fadillioglu E, Unal S,
  • Sogut S, Ozyurt H, Savas HA. The indices of
  • endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog
  • Neuropsychopharmacol Biol Psychiatry. 2002; 262995-1005. . Ozyurt B, Sarsilmaz M, Akpolat N, Ozyurt H, Akyol
  • O, Herken H, Kus I. The protective effects of omega
  • fatty acids against MK-801—induced neurotoxicity
  • in prefrontal cortex of rat. Neurochem Int. 2007; 50:196-202. . Herken H, Uz E, Ozyurt H, Akyol 0. Red blood cell
  • nitric oxide levels in patients with schizophrenia.
  • Schizophr Res. 2001; 52:289-90. . Özyurt B, Güleç M, Özyurt H, Ekici F, Atış Ö, Akbaş
  • A. The effect of antioxidant caffeic acid phenethyl es
  • ter (CAPE) on some enzyme activities in cisplatin
  • induced neurotoxicity in rats. Eur J Gen Med. 2006; 3:167-172. .Sud'ina GF, Mirzoeva OK, Pushkareva MA,
  • Korshunova GA, Sumbatyan NV, Varfolomeev SD.
  • Caffeic acid phenethyl ester as a lipoxygenase
  • inhibitor with antioxidant properties. FEBS Lett. 1993; 329:21-24.
  • Kocatepe Tıp Dergisi, Cil 7 No: 3, Eylül 2006.

MK-801 Verilen Ratlarm Cerebellumun'da Makromolekiiler Oksidasyon ve Cape'nin Koruyucu Etkisi

Year 2006, Volume: 7 Issue: 3, - , 01.12.2006

Abstract

Bu çalışmanın amacı MK-801 ile oluşan nörotoksisitede oksidatif stresin etkisini incelemek, oksidatif stresin önlenmesi ile prognozun düzelebileceğinin gösterilmesidir. MK-801 en nörotoksik NMDA reseptör antagonistlerinden biridir. Wistar Albino ratlar 3 gruba ayrıldı: l.grup: Kontrol, 2. grup: MK-80:l, 3. grup: MK— 801+CAPE. MK-80] beş gün intraperitoneal verildi. Tedavi grubuna MK—80l ’e maruzken CAPE verildi. Kontrol grubuna aynı sürede serum fizyolojik intraperitoneal verildi. 7 gün sonra ratlar dekapitasyonla öldürüldü. Serebellumları biyokimyasal analizler için çıkarıldı. Oksidatif stres parametresi olan Nitrik oksit (NO) yanı sıra Malondialdehit (MDA) ve Protein karbonil (PC) seviyeleri kontrol ile karşılaştırıldığında MK-801 grubu serebellumunda anlamlı artmıştı. CAPE ile tedavi edilen grupta NO, MDA ve PC seviyesi MK-80l grubu ile karşılaştırıldıgında ise anlamlı azaldı. Bu çalışmanın sonuçları serebellumda MK-801 ile oluşan nörotoksisitenin patogenesizinde oksidatif stresin önemli rolü olduğunu ortaya koydu. Bu deneysel çalışma aynı zamanda MK-80] ile oluşan nörotoksisite üzerine CAPE’nin koruyucu etkisi olabileceği yönünde bazı deliller sağlar

References

  • Olney JW, Newcomer JW, Farber NB. NMDA
  • receptor hypofunction model of schizophrenia. J
  • Psychiatr Res, 1999; 33:523-33.
  • Javitt DC, Zukin SR. Recent advances in the
  • phencyclidine model of schizophrenia. Am J
  • Psychiatry, 1991; [48:1301-8.
  • Corso TD, Sesma MA, Tenkova TI, Der TC,
  • Wozniak DF, Farber NB, Olney JW. Multifocal brain
  • damage induced by phencyclidine is augmented by
  • pilocarpine. Brain Res, 1997; 75221-14.
  • Haring R, Pellegrini-Giampietro DE, Zukin SR,
  • Zukin RS, Scheideler MA. High efŞciency
  • reconstitution of a phencyclidine/MK-801 receptor
  • binding site solubilized from rat forebrain
  • membranes. Mol Pharmacol. 1991; 402666-73.
  • Ferrer-Montiel AV, Sun W, Montal M. Molecular
  • design of the N—methyl-D-aspartate receptor binding
  • site for phencyclidine and dizolcipine. Proc Natl
  • Acad Sci U S A. 1995; 92:8021-5.
  • Hoffman DC. Typical and atypical neuroleptics
  • antagonize MK-801-induced locomotion and
  • stereotypy in rats. J Neural Transm Gen Sect. 1992;89:1-10.
  • Andine P, Widerrnark N, Axelsson R et al..
  • Characterization of MK-SOl-induced behavior as a
  • putative rat model of pschosis. JPET. 1999;290: 1393-1408.
  • Mastropaolo J, Rosse RB, Deutsch Sl. Anabasine, a
  • selective nicotinic acetylcholine receptor agonist,
  • antagonizes MK-801-elicited mouse popping
  • behavior, an animal model of schizophrenia. Behav
  • Brain Res. 2004. 31; 53z419-22.
  • Deutsch SI, Rosse RB, Billingslea EN, Bellack AS,
  • Mastropaolo J. Modulation of MK-801-elicited
  • mouse popping behavior by galantamine is complex
  • and dose-dependent. Life Sci. 2003. 7318:2355-61. . Rung JP, Carlsson A, Ryden Markinhuhta K,
  • Carlsson ML. (+)-MK—801 induced social withdrawal
  • in rats; a model for negative symptoms of
  • schizophrenia. Prog Neuropsychopharmacol Biol
  • Psychiatry. 2005. 29:827-32. . Nakki R, Sharp F., Sagar SM. FOS expression in the
  • brainstem and cerebellum following phencyclidine
  • and MK801. J Neurosci Res. 1996; 43:203-12.
  • Cortas, N. K., Wakid, N. W.:Determination of
  • inorganic nitrate in serum and urine by a kinetic
  • cadmium-reduction method. Clin Chem
  • ;36:1440-1443. . Esterbauer H, Cheeseman KH. Determination of
  • aldehydic lipid peroxidation products:
  • Malonaldehyde and 4-hydroxynonenal. ln Methods in
  • MK-801 Verilen Rat/arm Cerebellumun 'da Makromolekiiler Oksidasyon ve Cape ’nin Koruyucu Etkisi / 67 The Macromoleculer Oxıdation in Cerebellum of Rat Exposed To NIK-80] and The Protective Effect of Cape
  • EnzymolOgy, V 186, Oxygen radicals in biological
  • systems edited by Packer L, Glazer AN. Academic
  • Press, California, 1990, pp 407—421. . Packer L, Glazer NA. Determination of Carbonyl
  • Content in Oxidatively ModiŞed Proteins, Methods in
  • Enzymology. California. 1990;186:464-479. . Lowry O, Rosenbraugh N, Farr L, Rondall R. Protein
  • measurement with the folin-phenol reagent. J Biol
  • Chem 1951;183:265-275. . Mahadik SP, Evans D, Lal H. Oxidative stress and ro—
  • le of antioxidant and omega-3 essential fatty acid
  • supplementation in schizophrenia. Prog
  • Neuropsychopharmacol Biol Psychiatry. 2001; 25: 463-93. . Mahadik SP, Mukherjee S, Scheffer R, Correnti EE,
  • Mahadik JS. Elevated plasma lipid peroxides at the
  • onset of nonaffective psychosis. Biol Psychiatry.
  • ; 43:674-9. .Mates JM, Perez-Gomez C, De Castro IN.
  • Antioxidant enzymes and human diseases. Clin.
  • Biocehmistry. 1999; 32: 595—603. . Akyol O, Herken H, Uz E, Fadillioglu E, Unal S,
  • Sogut S, Ozyurt H, Savas HA. The indices of
  • endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog
  • Neuropsychopharmacol Biol Psychiatry. 2002; 262995-1005. . Ozyurt B, Sarsilmaz M, Akpolat N, Ozyurt H, Akyol
  • O, Herken H, Kus I. The protective effects of omega
  • fatty acids against MK-801—induced neurotoxicity
  • in prefrontal cortex of rat. Neurochem Int. 2007; 50:196-202. . Herken H, Uz E, Ozyurt H, Akyol 0. Red blood cell
  • nitric oxide levels in patients with schizophrenia.
  • Schizophr Res. 2001; 52:289-90. . Özyurt B, Güleç M, Özyurt H, Ekici F, Atış Ö, Akbaş
  • A. The effect of antioxidant caffeic acid phenethyl es
  • ter (CAPE) on some enzyme activities in cisplatin
  • induced neurotoxicity in rats. Eur J Gen Med. 2006; 3:167-172. .Sud'ina GF, Mirzoeva OK, Pushkareva MA,
  • Korshunova GA, Sumbatyan NV, Varfolomeev SD.
  • Caffeic acid phenethyl ester as a lipoxygenase
  • inhibitor with antioxidant properties. FEBS Lett. 1993; 329:21-24.
  • Kocatepe Tıp Dergisi, Cil 7 No: 3, Eylül 2006.
There are 77 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Birsen Ozyurt This is me

Huseyin Ozyurt This is me

Fatih Ekici This is me

Hasan Erdogan This is me

Mustafa Sarsılmaz This is me

Publication Date December 1, 2006
Published in Issue Year 2006 Volume: 7 Issue: 3

Cite

APA Ozyurt, B., Ozyurt, H., Ekici, F., Erdogan, H., et al. (2006). MK-801 Verilen Ratlarm Cerebellumun’da Makromolekiiler Oksidasyon ve Cape’nin Koruyucu Etkisi. Kocatepe Tıp Dergisi, 7(3). https://doi.org/10.18229/ktd.60395
AMA Ozyurt B, Ozyurt H, Ekici F, Erdogan H, Sarsılmaz M. MK-801 Verilen Ratlarm Cerebellumun’da Makromolekiiler Oksidasyon ve Cape’nin Koruyucu Etkisi. KTD. December 2006;7(3). doi:10.18229/ktd.60395
Chicago Ozyurt, Birsen, Huseyin Ozyurt, Fatih Ekici, Hasan Erdogan, and Mustafa Sarsılmaz. “MK-801 Verilen Ratlarm Cerebellumun’da Makromolekiiler Oksidasyon Ve Cape’nin Koruyucu Etkisi”. Kocatepe Tıp Dergisi 7, no. 3 (December 2006). https://doi.org/10.18229/ktd.60395.
EndNote Ozyurt B, Ozyurt H, Ekici F, Erdogan H, Sarsılmaz M (December 1, 2006) MK-801 Verilen Ratlarm Cerebellumun’da Makromolekiiler Oksidasyon ve Cape’nin Koruyucu Etkisi. Kocatepe Tıp Dergisi 7 3
IEEE B. Ozyurt, H. Ozyurt, F. Ekici, H. Erdogan, and M. Sarsılmaz, “MK-801 Verilen Ratlarm Cerebellumun’da Makromolekiiler Oksidasyon ve Cape’nin Koruyucu Etkisi”, KTD, vol. 7, no. 3, 2006, doi: 10.18229/ktd.60395.
ISNAD Ozyurt, Birsen et al. “MK-801 Verilen Ratlarm Cerebellumun’da Makromolekiiler Oksidasyon Ve Cape’nin Koruyucu Etkisi”. Kocatepe Tıp Dergisi 7/3 (December 2006). https://doi.org/10.18229/ktd.60395.
JAMA Ozyurt B, Ozyurt H, Ekici F, Erdogan H, Sarsılmaz M. MK-801 Verilen Ratlarm Cerebellumun’da Makromolekiiler Oksidasyon ve Cape’nin Koruyucu Etkisi. KTD. 2006;7. doi:10.18229/ktd.60395.
MLA Ozyurt, Birsen et al. “MK-801 Verilen Ratlarm Cerebellumun’da Makromolekiiler Oksidasyon Ve Cape’nin Koruyucu Etkisi”. Kocatepe Tıp Dergisi, vol. 7, no. 3, 2006, doi:10.18229/ktd.60395.
Vancouver Ozyurt B, Ozyurt H, Ekici F, Erdogan H, Sarsılmaz M. MK-801 Verilen Ratlarm Cerebellumun’da Makromolekiiler Oksidasyon ve Cape’nin Koruyucu Etkisi. KTD. 2006;7(3).

88x31.png
Bu Dergi Creative Commons Atıf-GayriTicari-AynıLisanslaPaylaş 4.0 Uluslararası Lisansı ile lisanslanmıştır.